Abstract:The impact of infections and inflammation during pregnancy on the developing fetal brain remains incompletely defined, with important clinical and research gaps. Although the classic infectious TORCH pathogens (ie, Toxoplasma gondii, rubella virus, cytomegalovirus [CMV], herpes simplex virus) are known to be directly teratogenic, emerging evidence suggests that these infections represent the most extreme end of a much larger spectrum of injury. We present the accumulating evidence that prenatal exposure to a wide variety of viral and bacterial infections-or simply inflammation-may subtly alter fetal brain development, leading to neuropsychiatric consequences for the child later in life. The link between influenza infections in pregnant women and an increased risk for development of schizophrenia in their children was first described more than 30 years ago. Since then, evidence suggests that a range of infections during pregnancy may also increase risk for autism spectrum disorder and depression in the child. Subsequent studies in animal models demonstrated that both pregnancy infections and inflammation can result in direct injury to neurons and neural progenitor cells or indirect injury through activation of microglia and astrocytes, which can trigger cytokine production and oxidative stress. Infectious exposures can also alter placental serotonin production, which can perturb neurotransmitter signaling in the developing brain. Clinically, detection of these subtle injuries to the fetal brain is difficult. As the neuropsychiatric impact of perinatal infections or inflammation may not be known for decades after birth, our construct for defining teratogenic infections in pregnancy (eg, TORCH) based on congenital anomalies is insufficient to capture the full adverse impact on the child. We discuss the clinical implications of this body of evidence and how we might place greater emphasis on prevention of prenatal infections. For example, increasing uptake of the seasonal influenza vaccine is a key strategy to reduce perinatal infections and the risk for fetal brain injury. An important research gap exists in understanding how antibiotic therapy during pregnancy affects the fetal inflammatory load and how to avoid inflammation-mediated injury to the fetal brain. In summary, we discuss the current evidence and mechanisms linking infections and inflammation with the increased lifelong risk of neuropsychiatric disorders in the child, and how we might improve prenatal care to protect the fetal brain.

Pathogenic Infections during Pregnancy and the Consequences for Fetal Brain Development

Consequences of Viral Infection and Cytokine Production During Pregnancy on Brain Development in Offspring

The fetal origins of mental illness

Intrauterine Viral Infections: Impact of Inflammation on Fetal Neurodevelopment

Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis

Viral infections in pregnancy and impact on offspring neurodevelopment: mechanisms and lessons learned

SARS-CoV-2 (COVID-19) as a possible risk factor for neurodevelopmental disorders

Neurodevelopmental implications of COVID-19-induced gut microbiome dysbiosis in pregnant women

Congenital Infection Influence on Early Brain Development Through the Gut-Brain Axis

Effects of Maternal SARS-CoV-2 Infection During Pregnancy on Fetal Development

Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders

Neurodevelopmental outcomes in congenital and perinatal infections

Deleterious Effects of Nervous System in the Offspring Following Maternal SARS-CoV-2 Infection During the COVID-19 Pandemic

COVID-19 and Its Potential Impact on Children Born to Mothers Infected During Pregnancy: A Comprehensive Review

Maternal respiratory viral infections during pregnancy and offspring's neurodevelopmental outcomes: A systematic review

Intrauterine exposure to SARS-CoV-2 infection and early newborn brain development

At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A

Maternal nutrients and effects of gestational COVID-19 infection on fetal brain development

Infections and Pregnancy: Effects on Maternal and Child Health

Maternal Immune Activation and Interleukin 17A in the Pathogenesis of Autistic Spectrum Disorder and Why It Matters in the COVID-19 Era

Prenatal SARS-CoV-2 infection results in neurodevelopmental and behavioral outcomes in mice